1. Home
  2. AVNW vs CRBP Comparison

AVNW vs CRBP Comparison

Compare AVNW & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVNW
  • CRBP
  • Stock Information
  • Founded
  • AVNW 2006
  • CRBP 2009
  • Country
  • AVNW United States
  • CRBP United States
  • Employees
  • AVNW N/A
  • CRBP N/A
  • Industry
  • AVNW Radio And Television Broadcasting And Communications Equipment
  • CRBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • AVNW Technology
  • CRBP Health Care
  • Exchange
  • AVNW Nasdaq
  • CRBP Nasdaq
  • Market Cap
  • AVNW 283.7M
  • CRBP 227.3M
  • IPO Year
  • AVNW 2007
  • CRBP N/A
  • Fundamental
  • Price
  • AVNW $14.44
  • CRBP $16.21
  • Analyst Decision
  • AVNW Strong Buy
  • CRBP Strong Buy
  • Analyst Count
  • AVNW 5
  • CRBP 7
  • Target Price
  • AVNW $38.60
  • CRBP $65.86
  • AVG Volume (30 Days)
  • AVNW 295.9K
  • CRBP 341.7K
  • Earning Date
  • AVNW 11-05-2024
  • CRBP 11-07-2024
  • Dividend Yield
  • AVNW N/A
  • CRBP N/A
  • EPS Growth
  • AVNW N/A
  • CRBP N/A
  • EPS
  • AVNW N/A
  • CRBP N/A
  • Revenue
  • AVNW $409,603,000.00
  • CRBP N/A
  • Revenue This Year
  • AVNW $11.69
  • CRBP N/A
  • Revenue Next Year
  • AVNW $5.33
  • CRBP N/A
  • P/E Ratio
  • AVNW N/A
  • CRBP N/A
  • Revenue Growth
  • AVNW 17.00
  • CRBP N/A
  • 52 Week Low
  • AVNW $12.96
  • CRBP $4.00
  • 52 Week High
  • AVNW $38.85
  • CRBP $61.90
  • Technical
  • Relative Strength Index (RSI)
  • AVNW 31.01
  • CRBP 34.43
  • Support Level
  • AVNW $13.95
  • CRBP $15.65
  • Resistance Level
  • AVNW $14.92
  • CRBP $17.18
  • Average True Range (ATR)
  • AVNW 0.99
  • CRBP 1.22
  • MACD
  • AVNW -0.02
  • CRBP 0.32
  • Stochastic Oscillator
  • AVNW 16.77
  • CRBP 13.57

About AVNW Aviat Networks Inc.

Aviat Networks Inc is a networking solutions provider. It designs, manufactures, and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: